Identifying predictors of outcome after intracerebral hemorrhage (ICH) may improve understanding of factors that contribute to recovery. We determined whether indices of renal insufficiency would predict early outcome in patients with ICH without established chronic kidney disease (CKD). Consecutive ICH patients discharged from a university stroke service between September 2005 and June 2009 were evaluated for proteinuria and estimated glomerular filtration rate (eGFR)<60 mL/min per 1.73 m(2) on admission. Patients with known CKD were excluded. The outcome assessed was discharge to home directly from the inpatient stroke service (vs transfer to rehabilitation, higher-level care unit, or nursing home). Independent effects of renal insufficiency on outcome were evaluated using multivariate regression modeling. Of 94 patients with recent ICH, 84 (89%) met the study inclusion criteria. In unadjusted analyses, patients discharged to home were less likely to have proteinuria (28% vs 57.9%; P=.02) and low eGFR (12.1% vs 30.2%; P=.06). After adjusting for 13 confounders, the likelihood of being discharged to home were lower in patients with initial proteinuria alone (odds ratio [OR]=0.41; 95% confidence interval [CI]=0.07-2.58), low eGFR alone (OR=0.24; 95% CI=0.04-1.39), or both conditions simultaneously (OR=0.20; 95% CI=0.02-1.76), but none of these associations reached statistical significance. In this study, proteinuria or low eGFR on admission were not independently linked with discharge directly to home. Larger studies are needed to further explore this issue, however.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.11.012 | DOI Listing |
Sci Adv
January 2025
Department of Cell Biology, Third Military Medical University, Chongqing, China.
The body weight-based thrombolytic medication strategy in clinical trials shows critical defects in recanalization rate and post-thrombolysis hemorrhage. Methods for perceiving thrombi heterogeneity of thrombolysis resistance is urgently needed for precise thrombolysis. Here, we revealed the relationship between the thrombin heterogeneity and the thrombolysis resistance in thrombi and created an artificial biomarker-based nano-patrol system with robotic functional logic to perceive and report the thrombolysis resistance of thrombi.
View Article and Find Full Text PDFJACC Case Rep
January 2025
Cardiology Department, Centre hospitalier de l'université de Montréal, Montréal, QC, Canada.
Left atrial myxoma is the most prevalent primary cardiac tumor, known for its high risk of systemic embolization. Although surgical excision remains the standard treatment, options are limited for high-risk patients. This case report introduces a novel approach using transcatheter electrosurgery to address a left atrial myxoma via a transseptal approach in a patient ineligible for conventional surgery due to the heightened risk of intracranial hemorrhage associated with cerebral amyloid angiopathy.
View Article and Find Full Text PDFAm J Transl Res
December 2024
Department of Pathology, Cangzhou People's Hospital Cangzhou 061000, Hebei, China.
Objective: To assess the predictive value of peripheral blood inflammatory markers for delayed cerebral ischemia (DCI) in patients with intracerebral hemorrhage (ICH) and explore methods for early intervention.
Methods: This single-center retrospective study reviewed medical records of ICH patients admitted to Cangzhou People's Hospital over a 12-month period from January 2022 to December 2023. Of the 150 identified patients with ICH, including 80 patients without DCI (control group) and 70 with DCI (observation group).
Am J Transl Res
December 2024
Department of Pediatrics, Yuyao People's Hospital Yuyao 315400, Zhejiang, China.
Objective: (UU) is an opportunistic pathogen transmitted from mother to fetus, potentially causing neonatal diseases. Despite extensive research, its association with these diseases remains uncertain. This study analyzes the effects of UU infection on newborns.
View Article and Find Full Text PDFCochrane Database Syst Rev
January 2025
Ageing Clinical and Experimental Research, University of Aberdeen, Aberdeen, UK.
Background: Aneurysmal subarachnoid haemorrhage continues to cause a significant burden of morbidity and mortality despite advances in care. Trials investigating local administration of thrombolytics have reported promising results.
Objectives: - To assess the effect of thrombolysis on improving functional outcome and case fatality following aneurysmal subarachnoid haemorrhage - To determine the effect of thrombolysis on the risk of cerebral artery vasospasm, delayed cerebral ischaemia, and hydrocephalus following subarachnoid haemorrhage - To determine the risk of complications of local thrombolysis in aneurysmal subarachnoid haemorrhage SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (last searched 9 March 2023), MEDLINE Ovid (1946 to 9 March 2023), and Embase Ovid (1974 to 9 March 2023).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!